Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies

Hepatocellular carcinoma (HCC) metabolism is redirected to glycolysis to enhance the production of metabolic compounds employed by cancer cells to produce proteins, lipids, and nucleotides in order to maintain a high proliferative rate. This mechanism drives towards uncontrolled growth and causes a...

Full description

Bibliographic Details
Main Authors: Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/6/1668
_version_ 1797564386499362816
author Monica Mossenta
Davide Busato
Michele Dal Bo
Giuseppe Toffoli
author_facet Monica Mossenta
Davide Busato
Michele Dal Bo
Giuseppe Toffoli
author_sort Monica Mossenta
collection DOAJ
description Hepatocellular carcinoma (HCC) metabolism is redirected to glycolysis to enhance the production of metabolic compounds employed by cancer cells to produce proteins, lipids, and nucleotides in order to maintain a high proliferative rate. This mechanism drives towards uncontrolled growth and causes a further increase in reactive oxygen species (ROS), which could lead to cell death. HCC overcomes the problem generated by ROS increase by increasing the antioxidant machinery, in which key mechanisms involve glutathione, nuclear factor erythroid 2-related factor 2 (Nrf2), and hypoxia-inducible transcription factor (HIF-1α). These mechanisms could represent optimal targets for innovative therapies. The tumor microenvironment (TME) exerts a key role in HCC pathogenesis and progression. Various metabolic machineries modulate the activity of immune cells in the TME. The deregulated metabolic activity of tumor cells could impair antitumor response. Lactic acid–lactate, derived from the anaerobic glycolytic rate of tumor cells, as well as adenosine, derived from the catabolism of ATP, have an immunosuppressive activity. Metabolic reprogramming of the TME via targeted therapies could enhance the treatment efficacy of anti-cancer immunotherapy. This review describes the metabolic pathways mainly involved in the HCC pathogenesis and progression. The potential targets for HCC treatment involved in these pathways are also discussed.
first_indexed 2024-03-10T18:56:36Z
format Article
id doaj.art-af85eef15ab640df9f0ea5c515fbea46
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T18:56:36Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-af85eef15ab640df9f0ea5c515fbea462023-11-20T04:42:44ZengMDPI AGCancers2072-66942020-06-01126166810.3390/cancers12061668Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic StrategiesMonica Mossenta0Davide Busato1Michele Dal Bo2Giuseppe Toffoli3Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), ItalyExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), ItalyExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), ItalyExperimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, 33081 Aviano (PN), ItalyHepatocellular carcinoma (HCC) metabolism is redirected to glycolysis to enhance the production of metabolic compounds employed by cancer cells to produce proteins, lipids, and nucleotides in order to maintain a high proliferative rate. This mechanism drives towards uncontrolled growth and causes a further increase in reactive oxygen species (ROS), which could lead to cell death. HCC overcomes the problem generated by ROS increase by increasing the antioxidant machinery, in which key mechanisms involve glutathione, nuclear factor erythroid 2-related factor 2 (Nrf2), and hypoxia-inducible transcription factor (HIF-1α). These mechanisms could represent optimal targets for innovative therapies. The tumor microenvironment (TME) exerts a key role in HCC pathogenesis and progression. Various metabolic machineries modulate the activity of immune cells in the TME. The deregulated metabolic activity of tumor cells could impair antitumor response. Lactic acid–lactate, derived from the anaerobic glycolytic rate of tumor cells, as well as adenosine, derived from the catabolism of ATP, have an immunosuppressive activity. Metabolic reprogramming of the TME via targeted therapies could enhance the treatment efficacy of anti-cancer immunotherapy. This review describes the metabolic pathways mainly involved in the HCC pathogenesis and progression. The potential targets for HCC treatment involved in these pathways are also discussed.https://www.mdpi.com/2072-6694/12/6/1668HCCglucose metabolismoxidative stresstumor microenvironmentanticancer-immunoresponse
spellingShingle Monica Mossenta
Davide Busato
Michele Dal Bo
Giuseppe Toffoli
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
Cancers
HCC
glucose metabolism
oxidative stress
tumor microenvironment
anticancer-immunoresponse
title Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
title_full Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
title_fullStr Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
title_full_unstemmed Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
title_short Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
title_sort glucose metabolism and oxidative stress in hepatocellular carcinoma role and possible implications in novel therapeutic strategies
topic HCC
glucose metabolism
oxidative stress
tumor microenvironment
anticancer-immunoresponse
url https://www.mdpi.com/2072-6694/12/6/1668
work_keys_str_mv AT monicamossenta glucosemetabolismandoxidativestressinhepatocellularcarcinomaroleandpossibleimplicationsinnoveltherapeuticstrategies
AT davidebusato glucosemetabolismandoxidativestressinhepatocellularcarcinomaroleandpossibleimplicationsinnoveltherapeuticstrategies
AT micheledalbo glucosemetabolismandoxidativestressinhepatocellularcarcinomaroleandpossibleimplicationsinnoveltherapeuticstrategies
AT giuseppetoffoli glucosemetabolismandoxidativestressinhepatocellularcarcinomaroleandpossibleimplicationsinnoveltherapeuticstrategies